HOXB13 and breast carcinoma: Results of these three studies have been pooled in a fixed-effects meta-analysis by Cai et al. and did not find a significant association between HOXB13 p.G84E and an increased breast cancer risk (OR = 1.42, 95% CI = 0.78–2.61, P = 0.26)7.